Table 3.
Clinical and Neuropathological Correlations in Alzheimer’s disease
Leg movement | Amount of leg movement | Hypersomnolence | Sleep difficulties | Hypocretin (Cytosolic) | Hypocretin (Membrane) | Alpha-synuclein (Cytosolic) | Alpha-synuclein (Membrane) | |
---|---|---|---|---|---|---|---|---|
Leg movements | 1.000 | 0.964(**) | −0.030 | 0.489(*) | 0.396 | 0.424 | −0.123 | 0.232 |
Amount of leg movements | 0.964(**) | 1.000 | 0.055 | 0.514(*) | 0.355 | 0.512(*) | −0.137 | 0.250 |
Hypersomnolence | −0.030 | 0.055 | 1.000 | 0.161 | 0.190 | 0.158 | −0.136 | 0.219 |
Sleep difficulties | 0.489(*) | 0.514(*) | 0.161 | 1.000 | 0.485 | 0.515(*) | −0.408 | −0.019 |
Hypocretin (Cytosolic) | 0.396 | 0.355 | 0.190 | 0.485 | 1.000 | 0.252 | −0.571(*) | −0317 |
Hypocretin (Membrane) | 0.424 | 0.512(*) | 0.158 | 0.515(*) | 0.252 | 1.000 | −0.309 | −0.057 |
Alpha-synuclein (Cytosolic) | −0.123 | −0.137 | −0.136 | −0.408 | −0.571(*) | −0.309 | 1.000 | 0.587(*) |
Alpha-synuclein (Membrane) | 0.232 | 0.250 | 0.219 | −0.019 | −0.317 | −0.057 | 0.587(*) | 1.000 |
Results are presented as just Spearman’s rank correlation coefficients or Spearman’s rank correlation coefficient (significance indicator)
indicates significance at the 0.01 level (2-tailed) and
indicates significance at the 0.05 level (2-tailed).
Significant results are presented in bold type.